Lucilia Saraiva

Porto, 4050313, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications

Overcoming radioresistance in prostate cancer by targeting DNA damage repair.

Overcoming radioresistance in prostate cancer by targeting DNA damage repair.

Journal: Cancer letters
Published: August 23, 2025

Hybrid Molecules of p53 Activators and Protoflavones to Target Multiple Myeloma.

Hybrid Molecules of p53 Activators and Protoflavones to Target Multiple Myeloma.

Journal: ChemMedChem
Published: July 16, 2025

Skin cancer chemoprevention: An overview.

Skin cancer chemoprevention: An overview.

Journal: Drug discovery today
Published: June 30, 2025

Design and Synthesis of Boronic Chalcones with Dual Anticancer and Anti-Inflammatory Activity.

Design and Synthesis of Boronic Chalcones with Dual Anticancer and Anti-Inflammatory Activity.

Journal: Molecules (Basel, Switzerland)
Published: June 11, 2025

Exploring the Anticancer Properties of 1,2,3-Triazole-Substituted Andrographolide Derivatives.

Exploring the Anticancer Properties of 1,2,3-Triazole-Substituted Andrographolide Derivatives.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 16, 2025

Mechanistic Insights of a p53-Targeting Small Molecule.

Mechanistic Insights of a p53-Targeting Small Molecule.

Journal: ACS pharmacology & translational science
Published: February 10, 2025

Correction: Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy.

Correction: Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy.

Journal: RSC medicinal chemistry
Published: January 20, 2025

A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer.

A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: December 27, 2024

P53 and the Ultraviolet Radiation-Induced Skin Response: Finding the Light in the Darkness of Triggered Carcinogenesis.

P53 and the Ultraviolet Radiation-Induced Skin Response: Finding the Light in the Darkness of Triggered Carcinogenesis.

Journal: Cancers
Published: October 24, 2024

Tryptophanol-derived oxazoloisoindolinone fluorescent probes for cellular localization studies of p53 activators.

Tryptophanol-derived oxazoloisoindolinone fluorescent probes for cellular localization studies of p53 activators.

Journal: Bioorganic chemistry
Published: July 09, 2024

3-Tetrazolyl-β-carboline derivatives as potential neuroprotective agents.

3-Tetrazolyl-β-carboline derivatives as potential neuroprotective agents.

Journal: Bioorganic & medicinal chemistry
Published: April 12, 2024

Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy.

Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy.

Journal: RSC medicinal chemistry
Published: January 26, 2024
Showing 1-12 of 93

Last Updated: 09/26/2026